Browse By: Country ι Category ι Latest Reports ι Tag
Home  »  Current Partnering

Current Partnering Market Research Reports

Current Partnering: The source of best practice for dealmakers

Current Partnering is the leading publisher of partnering deal terms and best practice for dealmakers. Report titles cover all aspects of partnering best practice and deal terms, providing users with the information and insight required to optimise their partnering activities. 



Genitourinary Deals and Alliances of 2014
The Genitourinary Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Genetic Disorders Deals and Alliances of 2014
The Genetic Disorders Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfron
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Gastrointestinal Deals and Alliances of 2014
The Gastrointestinal Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Central Nervous System Deals and Alliances of 2014
The Central Nervous System Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, u
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Cardiovascular Deals and Alliances of 2014
The Cardiovascular Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront,
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Hospital Care Deals and Alliances of 2014
The Hospital Care Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Autoimmune Partnering Terms and Agreements
The Autoimmune Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in autoimmune partnering deals Average deal terms for headline, upfront and royalty by stage of development Autoimmune partnering agreement structure Autoimmune partnering contract documents Top autoimmune deals by value Most active autoimmune dealmakers The Autoimmune Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and w
Published Date: Mar 2015
Published By: Current Partnering

Price: $2995
Non-Hodgkin Lymphoma Partnering 2010-2015
The Non-Hodgkin Lymphoma Partnering 2010-2015 report provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in non-hodgkin lymphoma partnering deals Top non-hodgkin lymphoma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Non-Hodgkin Lymphoma Partnering 2010-2015 provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of non-hodgkin lymphoma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors non-
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Big pharma Deals and Alliances of 2014
The Big Pharma Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during 2014. De
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Pharmaceutical Deals and Alliances of 2014
The Pharmaceutical Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront,
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Breast Cancer Partnering 2010-2015
The Breast Cancer Partnering 2010-2015 report provides understanding and access to the breast Cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in breast cancer partnering deals Top breast cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Breast Cancer Partnering 2010-2015 provides understanding and access to the breast cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of breast cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors breast cancer technology. These deals tend
Published Date: Mar 2015
Published By: Current Partnering

Price: $1795
Gastric Cancer Partnering 2010-2015
The Gastric Cancer Partnering 2010-2015 report provides understanding and access to the gastric cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gastric cancer partnering deals Top gastric cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Gastric Cancer Partnering 2010-2015 provides understanding and access to the gastric cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of gastric cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors gastric cancer technology. These dea
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Biotechnology Deals and Alliances of 2014
The Biotechnology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Specialty Pharma Deals and Alliances of 2014
The Specialty Pharma Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Big Biotech Deals and Alliances of 2014
A review of big biotech partnering trends and comprehensive directory of deals and alliances announced during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during 2014. Deals are listed by headline value, signed by bigbiotech, and most active bigbiotech. Where the deal has a
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Genomics Deals and Alliances of 2014
The Genomics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, most active de
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Companion Diagnostics Deals and Alliances of 2014
The Companion Diagnostics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Biomarker Deals and Alliances of 2014
The Biomarker Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, most active
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Congestive Heart Failure Partnering 2010-2015
The Congestive Heart Failure Partnering 2010-2015 report provides understanding and access to the congestive heart failure partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in congestive heart failure partnering deals Top congestive heart failure deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Congestive Heart Failure Partnering 2010-2015 provides understanding and access to the congestive heart failure partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of congestive heart failure partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an opti
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Traumatic Brain Injury Partnering 2010-2015
The Traumatic Brain Injury Partnering 2010-2015 report provides understanding and access to the traumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in traumatic brain injury partnering deals Top traumatic brain injury deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Traumatic Brain Injury Partnering 2010-2015 provides understanding and access to the traumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of traumatic brain injury partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to li
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Migraine Partnering 2010-2015
The Migraine Partnering 2010-2015 report provides understanding and access to the migraine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in migraine partnering deals Top migraine deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Migraine Partnering 2010-2015 provides understanding and access to the migraine partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of migraine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors migraine technology. These deals tend to be multicomponent, starting with coll
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Epilepsy Partnering 2010-2015
The Epilepsy Partnering 2010-2015 report provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in epilepsy partnering deals Top epilepsy deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Epilepsy Partnering 2010-2015 provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of epilepsy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors epilepsy technology. These deals tend to be multicomponent, starting with collab
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Oral Health Partnering 2010-2015
The Oral Health Partnering 2010-2015 report provides understanding and access to the oral health partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in oral health partnering deals Top oral health deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Oral Health Partnering 2010-2015 provides understanding and access to the oral health partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of oral health partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors oral health technology. These deals tend to be multicompone
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Cosmetics Partnering 2010-2015
The Cosmetics Partnering 2010-2015 report provides understanding and access to the cosmetics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cosmetics partnering deals Top cosmetics deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Cosmetics Partnering 2010-2015 provides understanding and access to the cosmetics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of cosmetics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cosmetics technology. These deals tend to be multicomponent, starting w
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Cervical Cancer Partnering 2010-2015
The Cervical Cancer Partnering 2010-2015 report provides understanding and access to the cervical cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cervical cancer partnering deals Top cervical cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Cervical Cancer Partnering 2010-2015 provides understanding and access to the cervical cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of cervical cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cervical cancer technology. T
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Dermatitis Partnering 2010-2015
The Dermatitis Partnering 2010-2015 report provides understanding and access to the dermatitis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dermatitis partnering deals Top dermatitis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dermatitis Partnering 2010-2015 provides understanding and access to the dermatitis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of dermatitis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dermatitis technology. These deals tend to be multicomponent, st
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Psoriasis Partnering 2010-2015
The Psoriasis Partnering 2010-2015 report provides understanding and access to the psoriasis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in psoriasis partnering deals Top psoriasis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Psoriasis Partnering 2010-2015 provides understanding and access to the psoriasis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of psoriasis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors psoriasis technology. These deals tend to be multicomponent, starting w
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Leukemia Partnering 2010-2015
The Leukemia Partnering 2010-2015 report provides understanding and access to the leukemia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in leukemia partnering deals Top leukemia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Leukemia Partnering 2010-2015 provides understanding and access to the leukemia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of leukemia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors leukemia technology. These deals tend to be multicomponent, starting with coll
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Liver Cancer Partnering 2010-2015
The Liver Cancer Partnering 2010-2015 report provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in liver cancer partnering deals Top Liver cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Liver Cancer Partnering 2010-2015 provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of liver cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors Liver cancer technology. These deals tend to be mu
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Lung Cancer Partnering 2010-2015
The Lung Cancer Partnering 2010-2015 report provides understanding and access to the lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in lung cancer partnering deals Top lung cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Lung Cancer Partnering 2010-2015 provides understanding and access to the lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of lung cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors lung cancer technology. These deals tend to be multicompo
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Pancreatic Cancer Partnering 2010-2015
The Pancreatic cancer Partnering 2010-2015 report provides understanding and access to the pancreatic cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in pancreatic cancer partnering deals Top pancreatic cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Pancreatic cancer Partnering 2010-2015 provides understanding and access to the pancreatic cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of pancreatic cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pancreatic canc
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Cancer Symptoms Partnering 2010-2015
The Cancer Symptoms Partnering 2010-2015 report provides understanding and access to the Cancer symptoms partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer symptoms partnering deals Top cancer symptoms deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Cancer Symptoms Partnering 2010-2015 provides understanding and access to the Cancer symptoms partnering deals and agreements entered into by the worlds leading healthcare companies. This report provides details of the latest cancer symptoms agreements announced in the healthcare sectors, covering: Symptoms Oral mucositis Cancer pain Bone Neuropathic Muscular Lymphoedema Alopecia Cachexia Ulcers Dys
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Myocardial Infarction Partnering 2010-2015
The Myocardial Infarction Partnering 2010-2015 report provides understanding and access to the myocardial infarction partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in myocardial infarction partnering deals Top myocardial infarction deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Myocardial Infarction Partnering 2010-2015 provides understanding and access to the myocardial infarction partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of myocardial infarction partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license t
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Hypercholesterolemia Partnering 2010-2015
The Hypercholesterolemia Partnering 2010-2015 report provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hypercholesterolemia partnering deals Top hypercholesterolemia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Hypercholesterolemia Partnering 2010-2015 provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of hypercholesterolemia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the lice
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Injectable Drug Delivery Partnering 2010-2015
Injectable Drug Delivery Partnering 2010-2015 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. Trends in injectable drug delivery partnering deals Top injectable drug delivery deals by value Deals listed by company A-Z, deal type, stage of development, therapy type Injectable Drug Delivery Partnering 2010-2015 provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter injectable drug delivery partnering deals. The majority of deals are discovery or development stage whereb
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Targeted Drug Delivery Partnering 2010-2015
Targeted Drug Delivery Partnering 2010-2015 report provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. Trends in targeted drug delivery partnering deals Top targeted drug delivery deals by value Deals listed by company A-Z, deal type, stage of development, therapy type Targeted Drug Delivery Partnering 2010-2015 provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter targeted drug delivery partnering deals. The majority of deals are discovery or development stage whereby th
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Antibody Deals and Alliances of 2014
The Antibody Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, most active
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Clinical Stage Deals and Alliances of 2014
The Clinical Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during 2014.
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Discovery Stage Deals and Alliances of 2014
The Discovery Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront,
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Respiratory Deals and Alliances of 2014
The Respiratory Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mil
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Public Health Deals and Alliances of 2014
The Public Health Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mil
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Ophthalmics Deals and Alliances of 2014
The Ophthalmics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mil
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Infectives Deals and Alliances of 2014
The Infectives Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mile
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Gynecology Deals and Alliances of 2014
The Gynecology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mile
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Infectious Vaccines Partnering Terms and Agreements
The Infectious Vaccines Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.  The report also includes adjuvant deals and alliances.   This report provides details of the latest infectious vaccines agreements announced in the healthcare sectors.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expec
Published Date: Jan 2015
Published By: Current Partnering

Price: $1995
Antibiotics Partnering Terms and Agreements
The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in antibiotics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Antibiotics partnering contract documents Top antibiotics deals by value   The Antibiotics Partnering Terms and Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter antibiotics partnering deals. The majority of deals are early development stage whereby
Published Date: Jan 2015
Published By: Current Partnering

Price: $1995
Antibody Partnering Terms and Agreements
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   This report provides details of the latest antibody agreements announced in the healthcare sectors, covering:   Antibodies Antibody-drug conjugates Monoclonal a
Published Date: Jan 2015
Published By: Current Partnering

Price: $2995
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals. Comprehensive directory of royalty financing deals since 2007 Royalty financing contract documents Royalty financing agreement terms Royalty financing agreement structure Top royalty financing deals by value Most active Royalty financing dealmakers The Royalty Financing Terms and Agreements report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter royalty financing partnering deals. Understand
Published Date: Dec 2014
Published By: Current Partnering

Price: $1995
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies. The report provides a detailed understand and analysis of how and why companies enter manufacturing and supply deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight wh
Published Date: Dec 2014
Published By: Current Partnering

Price: $3295
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics
The Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the asset purchase agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter asset purchase deals.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and
Published Date: Dec 2014
Published By: Current Partnering

Price: $2995
Oncology Partnering Terms and Agreements
The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology/cancer partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in oncology partnering deals Average deal terms for headline, upfront and royalty by stage of development Oncology partnering agreement structure Oncology partnering contract documents Top oncology deals by value Most active oncology dealmakers   The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis o
Published Date: Dec 2014
Published By: Current Partnering

Price: $2995
Ophthalmics Partnering Terms & Agreements
The Ophthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter ophthalmics partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors ophthalmics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   This report provides details of the latest ophthalmics deals and contracts announced in the healthcare sectors.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms.
Published Date: Dec 2014
Published By: Current Partnering

Price: $1995
Cancer Diagnostics Partnering Terms and Agreements
The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer diagnostics partnering contract documents Top cancer diagnostics deals by value   The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides an understanding and analysis of how and why companies enter cancer diagnostics partnering deals. The majority of dea
Published Date: Dec 2014
Published By: Current Partnering

Price: $2995
Gene Therapy Partnering Terms and Agreements
The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in gene therapypartnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Gene therapypartnering contract documents Top gene therapy deals by value   The Gene Therapy Partnering Terms and Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter gene therapypartnering deals. The majority of deals are early development stage wh
Published Date: Dec 2014
Published By: Current Partnering

Price: $1995
Dermatology Partnering Terms and Agreements
The Dermatology Partnering Terms and Agreementsreport provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals.  The majority of deals are marketed stage deals whereby the licensee obtains a marketing right or an option to co market or market the licensors dermatology product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.    This report provides details of the latest dermatology deals and contracts announced in the healthcare sectors.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the neg
Published Date: Dec 2014
Published By: Current Partnering

Price: $2995
Cancer Vaccine Partnering Terms and Agreements
The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer vaccine partnering contract documents Top cancer vaccine deals by value   The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides an understanding and analysis of how and why companies enter cancer vaccine partnering deals. The majority of deals are discovery or developmen
Published Date: Dec 2014
Published By: Current Partnering

Price: $1995
Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.   The report provides a detailed understand and analysis of how and why companies enter option and evaluation deals. The majority of deals are multicomponent whereby the licensor offers a right to option and evaluation the resultant product of the research collaboration. There are also numerous pure option and evaluation deals whereby the products originator takes on a partner in order to maximize a products presence in the marketplace.   Understanding the flexibility of a prospective partner’s n
Published Date: Nov 2014
Published By: Current Partnering

Price: $2995
Dementia Partnering 2009-2014
The Dementia Partnering 2009-2014 report provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dementia partnering deals Top dementia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dementia Partnering 2009-2014 provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of dementia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dementia technology. These deals tend to be multicomponent, starting with coll
Published Date: Nov 2014
Published By: Current Partnering

Price: $1795
Contraception Partnering 2009-2014
The Contraception Partnering 2009-2014 report provides understanding and access to the contraception partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in contraception partnering deals Top contraception deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Contraception Partnering 2009-2014 provides understanding and access to the contraception partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of contraception partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors contraception technology. These deals tend
Published Date: Nov 2014
Published By: Current Partnering

Price: $695
Pharmacogenomics Partnering Terms and Agreements
The Pharmacogenomics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter pharmacogenomics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pharmacogenomics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of
Published Date: Nov 2014
Published By: Current Partnering

Price: $1995
Personalized Medicine Partnering Terms and Agreements
Comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies.   The Personalized Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collabor
Published Date: Nov 2014
Published By: Current Partnering

Price: $3295
Biomarker Partnering Terms and Agreements
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers   The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter biomarker partnering deals. The majority of
Published Date: Nov 2014
Published By: Current Partnering

Price: $2995
Companion Diagnostics Partnering Terms & Agreements
The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter companion diagnostic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors companion diagnostics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight in
Published Date: Nov 2014
Published By: Current Partnering

Price: $1995
Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics
The Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies.   This new 1st edition, includes:   Trends in joint venture deals Joint venture agreement structure Joint venture contract documents Top joint venture deals by value Most active joint venture dealmakers Comprehensive directory of joint venture deals since 2009   This report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors.   The report provides details of joint venture agreements from 2009 to end of August 2014.   The report pr
Published Date: Oct 2014
Published By: Current Partnering

Price: $1995
Molecular Diagnostics Partnering Terms and Agreements
The Molecular Diagnostics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.     This report provides details of the latest molecular diagnostics agreements announced in the healthcare sectors.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - co
Published Date: Oct 2014
Published By: Current Partnering

Price: $1995
Regenerative Medicine Partnering Terms and Agreements
The Regenerative Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in regenerative medicine  Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for regenerative medicine and stem cells   The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine and stem cells partnering deals. The majority of deals are development stage whereby the licensee obtain
Published Date: Oct 2014
Published By: Current Partnering

Price: $2995
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you ca
Published Date: Sep 2014
Published By: Current Partnering

Price: $3295
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery stage partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you
Published Date: Sep 2014
Published By: Current Partnering

Price: $3295
Jazz Pharmaceuticals Partnering 2009-2014
The Partnering Agreements with Jazz Pharmaceuticals 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.   This report provides all the information you require to better understand Jazz Pharmaceuticals and its partnering interests and activities over the past seven years.   On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.   The report will be delivered in PDF format within 3 working days of receipt of order. If CD-Rom version purchased, the report will be sent by courier using express service.   One of the key aspects of partnering is finding those companies that are potential partners for the development
Published Date: Sep 2014
Published By: Current Partnering

Price: $995
Salix Pharmaceuticals Partnering 2009-2014
The Partnering Agreements with Salix Pharmaceuticals 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.   This report provides all the information you require to better understand Salix Pharmaceuticals and its partnering interests and activities over the past five years.   On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.   The report will be delivered in PDF format within 3 working days of receipt of order. If CD-Rom version purchased, the report will be sent by courier using express service.   One of the key aspects of partnering is finding those companies that are potential partners for the developmen
Published Date: Sep 2014
Published By: Current Partnering

Price: $995
Pharmacyclics Partnering 2009-2014
The Partnering Agreements with Pharmacyclics 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.   This report provides all the information you require to better understand Pharmacyclics and its partnering interests and activities over the past five years.   On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.   The report will be delivered in PDF format within 3 working days of receipt of order. If CD-Rom version purchased, the report will be sent by courier using express service.   One of the key aspects of partnering is finding those companies that are potential partners for the development and commercial
Published Date: Sep 2014
Published By: Current Partnering

Price: $995
Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech
The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the preclinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter preclinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   This report provides details of the latest preclinical agreements announced in the healthcare sector.   Understanding the flexibility of a prospective
Published Date: Sep 2014
Published By: Current Partnering

Price: $3295
Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics
The Collaborative R&D Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the collaborative R&D deals and agreements entered into by the worlds leading life science companies.   The report provides a detailed understand and analysis of how and why companies enter collaborative R&D deals.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract docum
Published Date: Aug 2014
Published By: Current Partnering

Price: $2995
Co-development Terms & Agreements in Pharma, Biotech and Diagnostics
The Co-development Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies.   The report provides a detailed understand and analysis of how and why companies enter co-development deals.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract documents provide this ins
Published Date: Aug 2014
Published By: Current Partnering

Price: $2995
Diagnostic Imaging Partnering Terms and Agreements
The Diagnostic Imaging Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter diagnostic imaging partnering deals.  This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering:   Imaging CT Endoscope Molecular and nuclear PET SPECT MRI Ultrasound X ray Angiography Fluoroscopy Mammography   This report provides an overview of diagnostic imaging dealmaking, the common clauses, rights and options in the partnering agreement, and also a comprehensive review o
Published Date: Aug 2014
Published By: Current Partnering

Price: $2995
Injectable Drug Delivery Partnering 2009-2014
Injectable Drug Delivery Partnering 2009-2014 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in injectable drug delivery partnering deals Top injectable drug delivery deals by value Deals listed by company A-Z, deal type, stage of development, therapy type   Injectable Drug Delivery Partnering 2009-2014 provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter injectable drug delivery partnering deals. The majority of deals are discovery or development stag
Published Date: Aug 2014
Published By: Current Partnering

Price: $995
Transdermal Drug Delivery Partnering 2009-2014
Transdermal Drug Delivery Partnering 2009-2014 report provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies.   Trends in transdermal drug delivery partnering deals Top transdermal drug delivery deals by value Deals listed by company A-Z, deal type, stage of development, therapy type   Transdermal Drug Delivery Partnering 2009-2014 provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter transdermal drug delivery partnering deals. The majority of deals are discover
Published Date: Aug 2014
Published By: Current Partnering

Price: $995
Topical Drug Delivery Partnering 2009-2014
Topical Drug Delivery Partnering 2009-2014 report provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies.   Trends in topical drug delivery partnering deals Top topical drug delivery deals by value Deals listed by company A-Z, deal type, stage of development, therapy type   Topical Drug Delivery Partnering 2009-2014 provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter topical drug delivery partnering deals. The majority of deals are discovery or development stage where
Published Date: Aug 2014
Published By: Current Partnering

Price: $995
Targeted Drug Delivery Partnering 2009-2014
Targeted Drug Delivery Partnering 2009-2014 report provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. Trends in targeted drug delivery partnering deals Top Targeted deals by value Deals listed by company A-Z, deal type, stage of development, therapy type Targeted Drug Delivery Partnering 2009-2014 provides understanding and access to the targeted partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter targeted drug delivery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a rig
Published Date: Aug 2014
Published By: Current Partnering

Price: $995
Antibody Deals and Alliances of 2013
The Antibody Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013.   Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2013’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2013 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during 2013
Published Date: Aug 2014
Published By: Current Partnering

Price: $1495
Genomics Deals and Alliances of 2013
The Genomics Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2013’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2013 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during 2013. Deal
Published Date: Aug 2014
Published By: Current Partnering

Price: $1495
Personalized Medicine in Oncology Partnering Terms and Agreements
The Personalized Medicine in Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter personalized medicine in oncology partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the n
Published Date: Aug 2014
Published By: Current Partnering

Price: $2995
Monoclonal Antibodies Partnering Terms and Agreements
The report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest monoclonal antibody deals announced in the healthcare sectors. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payment
Published Date: Aug 2014
Published By: Current Partnering

Price: $2995
Trends in Therapeutic Partnering
The Trends in Therapeutic Partnering report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2009 to mid 2014. The report provides a detailed understanding and analysis of the most popular therapeutic targets for partnering in the period 2009 to mid 2014. The majority of deals are discovery, preclinical and clinical stage whereby the licensee obtains a right or an option right to license or access the licensors compounds or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next gener
Published Date: Aug 2014
Published By: Current Partnering

Price: $3995
Cancer Monoclonal Antibody Partnering Terms and Agreements
The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer monoclonal antibody partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal antibody deals by value The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an understanding and analysis of how and why companies enter cancer monoclonal
Published Date: Aug 2014
Published By: Current Partnering

Price: $1995
Drug Delivery Partnering Terms and Agreements
The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors drug delivery technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of
Published Date: Jul 2014
Published By: Current Partnering

Price: $3295
Diagnostics Partnering Terms and Agreements
The Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter diagnostic partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors diagnostic technology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can
Published Date: Jul 2014
Published By: Current Partnering

Price: $3295
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for vaccines   The report provides a detailed understanding and analysis of how and why companies enter vaccine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative
Published Date: Jul 2014
Published By: Current Partnering

Price: $2995
Licensing Terms and Agreements in Pharma, Biotech and Diagnostics
The Licensing Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies. The report provides a detailed understand and analysis of how and why companies enter licensing deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract documents provide this insight where press releases
Published Date: Jul 2014
Published By: Current Partnering

Price: $3295
Partnering Agreements with Sun Pharmaceutical 2009-2014
The Partnering Agreements with Sun pharmaceutical 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.   This report provides all the information you require to better understand Sun pharmaceutical and its partnering interests and activities over the past seven years.   On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.   The report will be delivered in PDF format within 3 working days of receipt of order. If CD-Rom version purchased, the report will be sent by courier using express service.   One of the key aspects of partnering is finding those companies that are potential partners for the development and
Published Date: Apr 2014
Published By: Current Partnering

Price: $995
Partnering Deals and Alliances with Big Pharma
The Partnering Deals and Alliances with Big Pharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big pharma companies.   Partnering Deals and Alliances with Big Pharma provides the user with the following key benefits:   Detailed partnering activity profiles for each of the top 50 big pharma companies Over 300 charts showing a company’s dealmaking activity since 2007, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2009 – number of deals per year Full listing of partnering deals Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by th
Published Date: Mar 2014
Published By: Current Partnering

Price: $3295
Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
The Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery, preclinical and clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter discovery, preclinical and clinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   Understanding the flexibility of a prospective partner’s negotiated deals terms pro
Published Date: Mar 2014
Published By: Current Partnering

Price: $5495
Partnering Deals and Alliances with Big Biotech
The Partnering Deals and Alliances with Big Biotech report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big biotech companies.   Partnering Deals and Alliances with Big Biotech provides the user with the following key benefits:   Detailed partnering activity profiles for each of the top 50 big biotech companies Over 300 charts showing a company’s dealmaking activity since 2009, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2009 – number of deals per year Full listing of partnering deals Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by th
Published Date: Mar 2014
Published By: Current Partnering

Price: $2195
Obstetrics Partnering Terms and Agreements
The Obstetrics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the obstetrics partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter obstetrics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors obstetrics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can e
Published Date: Feb 2014
Published By: Current Partnering

Price: $1995
Bigpharma Deals and Alliances of 2013
The Bigpharma Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013.   Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.   The initial chapters of this report provide an orientation of 2013’s dealmaking and business activities.   Chapter 1 provides an overview of the trends in dealmaking during 2013 covering trends by deal type, stage of development, technology type and therapeutic indication.   Chapter 2 provides a review of the leading
Published Date: Feb 2014
Published By: Current Partnering

Price: $1495
Pharmaceutical Deals and Alliances of 2013
The Pharmaceutical Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013.   Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.   The initial chapters of this report provide an orientation of 2013’s dealmaking and business activities.   Chapter 1 provides an overview of the trends in dealmaking during 2013 covering trends by deal type, stage of development, technology type and therapeutic indication.   Chapter 2 provides a review of the lea
Published Date: Feb 2014
Published By: Current Partnering

Price: $1495
Biotechnology Deals and Alliances of 2013
The Biotechnology Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013.   Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.   The initial chapters of this report provide an orientation of 2013’s dealmaking and business activities.   Chapter 1 provides an overview of the trends in dealmaking during 2013 covering trends by deal type, stage of development, technology type and therapeutic indication.   Chapter 2 provides a review of the lead
Published Date: Feb 2014
Published By: Current Partnering

Price: $1495
Merger and Acquisition Deals and Alliances of 2013
The Merger and Acquisition Deals and Alliances of 2013 provides comprehensive understanding and unprecedented access to the M&A deals and agreements entered into by the worlds leading healthcare companies during 2013.   Using these reports, dealmakers will effectively and efficiently gain insight into the M&A activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.   The initial chapters of this report provide an orientation of 2013’s M&A dealmaking and business activities.   Chapter 1 provides an overview of the trends in M&A dealmaking during 2013.   Chapter 2 provides a review of the leading M&A deals during 2013. Deals are listed by headline value, signed by bigpha
Published Date: Feb 2014
Published By: Current Partnering

Price: $1495
Big Biotech Deals and Alliances of 2013
A review of big biotech partnering trends and comprehensive directory of deals and alliances announced during 2013.   Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.   The initial chapters of this report provide an orientation of 2013’s dealmaking and business activities.   Chapter 1 provides an overview of the trends in dealmaking during 2013 covering trends by deal type, stage of development, technology type and therapeutic indication.   Chapter 2 provides a review of the leading deals during 2013. Deals are listed by headline value, signed by bigbiotech, and most active bigbiotech
Published Date: Feb 2014
Published By: Current Partnering

Price: $1495
Distribution partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Distribution Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies.   The report provides a detailed understand and analysis of how and why companies enter distribution deals.   The majority of deals are multicomponent whereby the licensor offers a right to distribute the resultant product of the research collaboration. There are also numerous pure distribution deals whereby the products originator takes on a distribution partner in order to maximize a products presence in the marketplace.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotia
Published Date: Dec 2013
Published By: Current Partnering

Price: $2995